Current Assets
Derivative Assets - Fair Value
Edwards Lifesciences Derivative Assets - Fair Value increased by 144.8% to $14.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 46.6%, from $26.60M to $14.20M. Over 2 years (FY 2023 to FY 2025), Derivative Assets - Fair Value shows a downward trend with a -50.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2023
Last reportedQ1 2026May 6, 2026
How to read this metric
Higher values indicate successful hedging outcomes or favorable market shifts, whereas lower values suggest reduced hedging gains.
Detailed definition
This metric captures the total fair value of all derivative financial instruments that are currently in an asset positio...
Peer comparison
Highly comparable across energy and commodity-intensive firms that utilize extensive hedging programs.
Metric ID:
derivative_assets_fair_valueHistorical Data
10 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.40M | $27.90M | $30.50M | $21.80M | $34.70M | $26.60M | $3.10M | $5.10M | $5.80M | $14.20M |
| QoQ Change | — | +19.2% | +9.3% | -28.5% | +59.2% | -23.3% | -88.3% | +64.5% | +13.7% | +144.8% |
| YoY Change | — | — | — | — | +48.3% | -4.7% | -89.8% | -76.6% | -83.3% | -46.6% |
Range$3.10M – $34.70M
CAGR-19.9%
Avg YoY Growth-42.1%
Median YoY Growth-61.6%
Current Streak3 quarters growth
Derivative Assets - Fair Value at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's derivative assets - fair value?
- Edwards Lifesciences (EW) reported derivative assets - fair value of $14.20M in Q1 2026.
- How has Edwards Lifesciences's derivative assets - fair value changed year-over-year?
- Edwards Lifesciences's derivative assets - fair value decreased by 46.6% year-over-year, from $26.60M to $14.20M.
- What is the long-term trend for Edwards Lifesciences's derivative assets - fair value?
- Over 2 years (2023 to 2025), Edwards Lifesciences's derivative assets - fair value has grown at a -50.2% compound annual growth rate (CAGR), from $23.40M to $5.80M.
- What does derivative assets - fair value mean?
- The total market value of all derivative contracts that are currently profitable.